innovent glp-1 Innovent's GLP-1RA bests semaglutide's glycaemic control in Phase III Innovent gets IND for oral
Description
If eligible, the provider prescribes an FDA-approved GLP-1
The most recently approved FDA medication for the treatment of obesity, tirzepatide, exerts its physiologic effects as a dual GLP-1R and Gastric Inhibitory Polypeptide Receptor (GIP-R) agonist with better efficacy than the standalone GIP-R agonist semaglutide [39]
Physicians should balance the benefits and potential risks of semaglutide in their clinical decisions [63]
GLP-1 at the metabolic-cognitive interface: reward, affect, and memory
Norris began losing his vision after using Mounjaro in 2023, while Bovee became legally blind following Ozempic use
